MedTrace Logo

Study to Investigate the Effect of Deferasirox on the Pharmacokinetics of Midazolam

NCT00427505 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2009-11-19

No results posted yet for this study

Summary

This is a study to investigate the pharmacokinetics of deferasirox

Conditions

  • Healthy

Interventions

DRUG

Deferasirox

Sponsors & Collaborators

Principal Investigators

  • Novartis · Novartis

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-07-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00427505 on ClinicalTrials.gov